| 1. |
Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations. Clin Chest Med, 2020, 41(3): 421-438.
|
| 2. |
Wang Z, Locantore N, Haldar K, et al. Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis. Am J Respir Crit Care Med, 2021, 203(12): 1488-1502.
|
| 3. |
Torres-Sánchez I, Valenza MC, Cebriá I Iranzo MDà, et al. Effects of different physical therapy programs on perceived health status in acute exacerbation of chronic obstructive pulmonary disease patients: a randomized clinical trial. Disabil Rehabil, 2018, 40(17): 2025-2031.
|
| 4. |
MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: diagnosis, treatment, prevention and disease impact. Respirology, 2021, 26(6): 532-551.
|
| 5. |
曹校校, 傅安安, 陳榮, 等. 血清高敏C-反應蛋白、腫瘤壞死因子-α聯合肺功能檢測在診斷慢性阻塞性肺疾病中的應用價值分析. 中國衛生檢驗雜志, 2020, 30(3): 346-348,351.
|
| 6. |
Lin SH, He YP, Lian JJ, et al. Procalcitonin kinetics to guide sequential invasive-noninvasive mechanical ventilation weaning in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: procalcitonin's adjunct role. Libyan J Med, 2021, 16(1): 1961382.
|
| 7. |
Ghobadi H, Hosseini N, Aslani MR. Correlations between serum decoy receptor 3 and airflow limitation and quality of life in male patients with stable stage and acute exacerbation of COPD. Lung, 2020, 198(3): 515-523.
|
| 8. |
Jin ZJ, Liu SQ, Zhan Q, et al. Decoy receptor 3 alleviates hepatic fibrosis through suppressing inflammation activated by NF-κB signaling pathway. Adv Clin Exp Med, 2018, 27(4): 441-447.
|
| 9. |
中華醫學會呼吸病學分會慢性阻塞性肺疾病學組. 慢性阻塞性肺疾病診治指南(2013年修訂版). 中華結核和呼吸雜志, 2013, 36(4): 255-264.
|
| 10. |
中華醫學會心血管病學分會心力衰竭學組, 中國醫師協會心力衰竭專業委員會, 中華心血管病雜志編輯委員會. 中國心力衰竭診斷和治療指南2018. 中華心血管病雜志, 2018, 46(10): 760-789.
|
| 11. |
Hattab Y, Alhassan S, Balaan M, et al. Chronic obstructive pulmonary disease. Crit Care Nurs Q, 2016, 39(2): 124-130.
|
| 12. |
Gilani MT, Razavi M, Azad AM. A comparison of Simplified Acute Physiology Score II, Acute Physiology and Chronic Health Evaluation II and Acute Physiology and Chronic Health Evaluation III scoring system in predicting mortality and length of stay at surgical intensive care unit. Niger Med J, 2014, 55(2): 144-147.
|
| 13. |
van Eeden SF, Hogg JC. Immune-modulation in chronic obstructive pulmonary disease: current concepts and future strategies. Respiration, 2020, 99(7): 550-565.
|
| 14. |
Singh D, Long G, Can?ado JED, et al. Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinician. Curr Opin Pulm Med, 2020, 26(2): 162-168.
|
| 15. |
Tan DY, Walline JH, Ling BY, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial. Crit Care, 2020, 24(1): 489.
|
| 16. |
Liu LL, Luan Y, Xiao L, et al. The predictive value of serum procalcitonin for non-invasive positive pressure ventilation in the patients with acute exacerbation of chronic obstructive pulmonary disease. Medicine (Baltimore), 2021, 100(16): e25547.
|
| 17. |
Bremmer DN, Moffa MA, Ma K, et al. Acute exacerbations of chronic obstructive pulmonary disease with a low procalcitonin concentration: impact of antibiotic therapy. Clin Infect Dis, 2019, 68(5): 725-730.
|
| 18. |
Ding GZ, Li WS. The expressions and significance of APN, D-D, IL-17 and hs-CRP in patients with acute exacerbation of chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci, 2018, 22(19): 6463-6468.
|
| 19. |
程蕾, 劉杰峰, 龐劍, 等. 血清同型半胱氨酸、D-二聚體及前白蛋白與慢性阻塞性肺疾病急性加重合并呼吸衰竭相關性. 臨床軍醫雜志, 2020, 48(12): 1479-1481.
|
| 20. |
Bou-Dargham MJ, Liu YH, Sang QA, et al. Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3. PLoS One, 2018, 13(12): 207799.
|
| 21. |
Fukuda K, Miura Y, Maeda T, et al. Expression profiling of genes in rheumatoid fibroblast-like synoviocytes regulated by tumor necrosis factor-like ligand 1A using cDNA microarray analysis. Biomed Rep, 2019, 1(1): 11-18.
|
| 22. |
劉敏, 王立芹, 楊茂勇, 等. 血清腫瘤壞死因子受體-6水平對AECOPD合并呼吸衰竭患者轉歸的影響. 中國醫師雜志, 2019, 21(8): 1181-1184, 1189.
|
| 23. |
趙佳媛, 許婷婷, 吳笛, 等. DcR3 ALB水平與慢阻肺急性加重期合并呼衰患者轉歸關系. 河北醫學, 2021, 27(9): 1436-1440.
|